用户名/邮箱
登录密码
验证码
看不清?换一张
您好,欢迎访问! [ 登录 | 注册 ]
您的位置:首页 - 最新资讯
Trump's new vaccine chief will donate stock windfall to cancer research
2020-05-18 00:00:00.0     美国有线电视-特朗普新闻     原网页

       (CNN)The newly appointed top adviser to President Donald Trump's rapid-pace vaccine effort will donate proceeds from a Moderna stock windfall to cancer research, the administration said on Monday.

       Promising news on a coronavirus vaccine from Moderna sent the biotechnology firm's stock soaring on Monday -- a potential boon for its onetime board member Moncef Slaoui, who was formally appointed Friday as the chief scientist to Trump's "Operation Warp Speed" vaccine initiative.

       Slaoui stepped down from Moderna's board after Trump selected him to help lead the Manhattan Project-like effort to develop a coronavirus vaccine, aiming to have substantial quantities of a safe and effective vaccine available for Americans by January.

       But recent filings with the Securities and Exchange Commission show he held stock options in the company that were worth millions even before the price spiked on Monday.

       White House announces new additions to coronavirus task force

       A spokeswoman for the Department of Health and Human Services said Monday that Slaoui was divesting his holdings in Moderna and it was likely the sale would be complete by Tuesday morning.

       Read More

       The spokeswoman, Caitlin Oakley, said Slaoui "has committed to donate to cancer research all incremental value accrued from his Moderna shares between the evening of Thursday, May 14, prior to the announcement of his position on Operation Warp Speed and the time of sale, scheduled for tomorrow (Tuesday) morning."

       A longtime vaccine researcher, Slaoui stepped down from his post atop GlaxoSmithKline's global vaccines business in 2017. Before that, he acted as the pharmaceutical giant's longtime chairman of global research and development. He helped develop vaccines to prevent infantile rotavirus gastroenteritis, cervical cancer and shingles.

       During a Rose Garden ceremony on Friday, Slaoui characterized Trump's goal of developing a coronavirus vaccine by the end of the year as attainable, albeit difficult.

       "I believe they are very credible. I also believe they are extremely challenging," Slaoui said.

       Paid Content

       Instantly unblock Gmail, Google, Facebook, Twitter, Instagram &… expressvpn

       China’s challenges in tackling COVID-19 CGTN

       Learning a new language this year? – This app gets you speaking in just 3 weeks Babbel

       Why Is Everybody Snapping Up This New $49 Smartwatch? OshenWatch

       The ‘nurse’ mistaken for a person-in-the-know CGTN

       Politics White House trade adviser: CDC let country down on testing

       Politics How Donald Trump wins again, in 3 sentences

       U.S. Hear Bill Clinton's remarks to the Class of 2020

       Asia Drug bust in Myanmar nets haul likely worth hundreds of millions…

       Politics Tapper presses GOP Senator for facts on 'conspiracy'

       Delivering to keep Beijingers safe during the outbreak CGTN

       Only a few have discovered this tool that has changed their leisure… ExpressVPN

       Access Hundreds of New Titles While Staying at Home! ExpressVPN

       China: New WiFi Booster Stops Expensive Internet Next Tech

       


标签:综合
关键词: Trump's     Monday     Moderna     coronavirus     vaccine initiative     ExpressVPN     Slaoui     firm's stock soaring     cancer research    
滚动新闻